news CRISPR approach could limit toxicity of CAR-T therapy in AML New study uses CRISPR/Cas9 to make CD33 CAR T cells… 4 June 2018 | By Dr Zara Kassam (Drug Target Review) New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...